CLOs on the Move

Q2 Solutions

www.q2labsolutions.com

 
Q² Solutions, a Quintiles Quest joint venture Launched in 2015, Q² Solutions (pronounced Q-squared) is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q² Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q² Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Cell Science Systems Limited Corp

Cell Science Systems Limited Corp is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Deerfield Beach, FL. To find more information about Cell Science Systems Limited Corp, please visit www.alcat.com

YourPath

YourPath is a healthcare provider that offers medication-assisted treatment and comprehensive assessments for individuals affected by substance use disorders.

Freedom Imaging

Freedom Imaging is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tucson Medical Center

Tucson Medical Center, licensed at 607 beds, has been Tucson`s locally governed nonprofit regional hospital for 70 years. TMC is Southern Arizona`s leading provider for emergency care and pediatric care (including Tucson`s first Pediatric Emergency Department), with top-notch intensive care units for adults, children and newborns. Other specialty areas include women`s, maternity, cardiovascular, orthopaedic, neuroscience, hospice, imaging and senior services. TMC earned certification as a Primary Stroke Center, accreditation as a Chest Pain Center, and the Gold Plus Achievement Award for stroke programs from the American Heart Association/American Stroke Association. TMC is also a recipient of the AHA/ASA`s Target: Stroke Honor Roll. TMC HealthCare is Southern Arizona`s locally governed nonprofit system, the corporate entity that includes Tucson Medical Center and Saguaro Physicians.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.